The zinc preparation polaprezinc is approved for treating gastric ulcers and its safety confirmed. To clarify its efficacy against taste disorder, we studied its effects on histopathological epithelial tongue changes and taste bud cell cycle regulation in zinc-deficient rats, an animal taste disturbance model.
Exp. I; Four-week-old SD rats were placed on 4-week zinc-deficient diets. During the ensuing 4 weeks, polaprezinc was administered orally at doses of 0, 1, 3 and 10mg/kg/day with zinc-deficient diets. The tongue was histopathologically studied. Exp. II; Histopathological time courses of 0, 1, 2, 3 and 4 weeks was studied in 3mg/kg groups of polaprezinc.
Parakeratosis was observed in rats on the zinc-deficient diet and 1mg/kg polaprezinc but not in these administered 3 and 10mg/kg of polaprezinc. The ratios of keratinizing epithelium, including parakeratosis, in the outer and inner circumference of circumvallate papilla increased in zinc-deficient rats - these increases reversed in rats administered polaprezinc. Proliferating antigen-positive taste bud cells decreased in zinc-deficient rats - the decrease reversed in those administered polaprezinc. Based on time-course observation, cellular taste bud proliferation recovered to normal after 2 weeks of polaprezinc administration and parakeratosis normalized after 3 weeks of administration.
Polaprezinc thus ameliorated parakeratosis and decreased taste bud cell proliferation caused by zinc deficiency. These effects may involve mechanisms underlying taste disorder improvement in animal models. These results suggest that zinc plays a significant role in taste organ morphology and function of, and that polaprezinc is efficacious in treating taste disorder.
View full abstract